Stage III Grade 3 Follicular Lymphoma Completed Phase 1 Trials for Cilengitide (DB11890)

IndicationStatusPhase
DBCOND0028630 (Stage III Grade 3 Follicular Lymphoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00077155Cilengitide (EMD 121974) in Treating Patients With Advanced Solid Tumors or LymphomaTreatment